Show simple item record

dc.contributor.authorLi, Lian-Yun ( )
dc.contributor.authorMa, Ruo-Lan ( )
dc.contributor.authorDu, Liqin ( Orcid Icon 0000-0002-7097-5861 )
dc.contributor.authorWu, An-Shi ( )
dc.date.accessioned2019-10-17T15:24:57Z
dc.date.available2019-10-17T15:24:57Z
dc.date.issued2017-08
dc.identifier.citationLi, L., Ma, R., Du, L., & Wu, A. (2017). Ozonated autohemotherapy modulates the serum levels of inflammatory cytokines in gouty patients. Open Access Rheumatology: Research and Reviews, 9, pp. 159-165.en_US
dc.identifier.issn1179-156X
dc.identifier.urihttps://digital.library.txstate.edu/handle/10877/8676
dc.description.abstract

Objectives: Ozonated autohemotherapy (O3-AHT) has been used to effectively treat gout, but the underlying therapeutic mechanisms remain unknown. In this study, as an initial effort to understand the therapeutic mechanisms of O3-AHT, we aim to examine the effect of O3-AHT on serum inflammatory cytokine levels in gouty patients.

Patients and Methods: Three groups of patients and healthy subjects were recruited, including the gouty (n=10), hyperuricemia (n=10), and healthy control (n=11) groups. Cytometric bead array was applied to examine 12 cytokines before (T0), during (T1), and after (T2) therapies.

Results: Three cytokines, IL-8, IL-12, and MCP-1, were detectable in all participants. Before O3-AHT, the average serum levels of IL-8 and MCP-1 were higher in the gout group than in the hyperuricemia and healthy control groups, confirming the inflammation status in gouty patients. After the 5th course of O3-AHT (T1), IL-8 level was significantly increased compared to that at T0. IL-12 level was also raised at T1, although the difference did not reach statistical significance. After completing the therapy, both IL-8 and IL-12 levels decreased to levels lower than those at T0. MCP-1 level remained essentially unchanged during and after treatment.

Conclusion: Our results indicate that O3-AHT induces a significant change in serum cytokine levels, suggesting that modulating the inflammatory process is one of the therapeutic mechanisms underlying O3-AHT. In addition, the sensitive response of serum IL-8 and IL-12 levels to O3-AHT suggests that these cytokines may be developed as biomarkers to evaluate the therapeutic effect of O3-AHT in gouty patients.

en_US
dc.formatText
dc.format.extent7 pages
dc.format.medium1 file (.pdf)
dc.language.isoen
dc.publisherDove Medical Pressen_US
dc.sourceOpen Access Rheumatology: Research and Reviews, 2017, Vol. 9, pp. 159-165
dc.subjectOzonated autohemotherapy
dc.subjectInflammation
dc.subjectCytokine
dc.subjectGouten_US
dc.titleOzonated Autohemotherapy Modulates the Serum Levels of Inflammatory Cytokines in Gouty Patientsen_US
dc.typepublishedVersion
txstate.documenttypeArticle
dc.rights.holder© 2017 Li et al.
dc.identifier.doihttps://doi.org/10.2147/OARRR.S119749
dc.rights.licenseCreative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License.
dc.description.departmentChemistry and Biochemistry


Download

Thumbnail

This item appears in the following Collection(s)

Show simple item record